Eagle Bay Advisors LLC Exelixis, Inc. Transaction History
Eagle Bay Advisors LLC
- $170 Million
- Q3 2024
A detailed history of Eagle Bay Advisors LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 489 shares of EXEL stock, worth $17,364. This represents 0.01% of its overall portfolio holdings.
Number of Shares
489
Previous 135
262.22%
Holding current value
$17,364
Previous $3,000
300.0%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EXEL
# of Institutions
468Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$1.19 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$1.05 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$962 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$538 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$447 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.4B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...